Extracorporeal Membrane Oxygenation (ECMO) Market is Expected To Reach USD 385.9 Million By 2028 at a CAGR of 3.6%

Increasing prevalence of infectious, cardiovascular and respiratory diseases, growing adoption of ECMO in lung transplantation procedures, growth in the number of ECMO centers, increasing survival rates with ECMO and increasing strategic initiatives such as product launch or collaboration are key factors contributing to high CAGR of Extracorporeal Membrane Oxygenation (ECMO) Market during forecast period.

According to the current analysis of Reports and Data, the global Extracorporeal Membrane Oxygenation (ECMO) market was valued at USD 290.2 Million in 2020 and is expected to reach USD 385.9 Million by the year 2028, at a CAGR of 3.6%. Extracorporeal membrane oxygenation  is a treatment provided for COVID-19, cardiac and respiratory diseases. Increasing the prevalence of target diseases (such as COVID-19, cardiovascular diseases and respiratory diseases), technological advancements, and increasing extracorporeal membrane oxygenation centers across the globe are some of the factors driving the market growth. It is estimated that in the U.S., approximately 1,055,000 individuals will have coronary diseases, including 720,000 new and 335,000 recurrent coronary events. The number of artificial respiration via the help of the device in a developed nation such as the U.S. from the past decade is constantly on rise. With rising technological innovations improved survival rate with extracorporeal membrane oxygenation is another major factor that supports the spread of the adoption of extracorporeal membrane oxygenation in case of medical emergencies such as COVID-19 cases.  In South Korea it has been observed that the inpatient with Extracorporeal membrane oxygenation therapy for respiratory failure had  improved survival rate from 30.8% to 35.9%.

Access Free sample PDF Copy of the Report (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/2465

According to the Extracorporeal Life Support Organization (ELSO), the number of hospitals offering ECMO services reached 264 in 2020, rising from 108 in 2008. Obesity often leads to poor vascular health and an increased risk of cardiovascular disease (CVD). With advent of COVID pandemic the demand for the device is expected to surge further. . However, stringent regulations in developed nations, and high associated cost of the procedure may hinder market growth in developing nations.

Further key findings from the report suggest

• Recently, Terumo and Marker Therapeutics received FDA approval for a blood purification and oxygenation system in the treatment of COVID-19 infection. Terumo’s Spectra Optia apheresis system works with the Marker Therapeutics’ Depuro D2000 adsorption cartridges. It reduces the number of cytokines and other inflammatory blood proteins that control a cell’s immune response then filter the blood and return it to the patient. According to the FDA the proteins that are removed are typically elevated during infections, leading to severe inflammation, rapidly progressive shock, respiratory failure, organ failure and death.
• Various organizations and research institutes are engaged in clinical trials of the extracorporeal membrane oxygenation for cardiac and respiratory diseases. For instance, NHS ECMO completed the study of the ECMO service for adults with respiratory failure. Central Hospital, Nancy, France is engaged in studying the efficacy of Venoarterial Extracorporeal Membrane Oxygenation prior the left ventricular assist device implantation
• Favorable reimbursement policy such as, Medicare and Medicaid reimburse the patients going through extracorporeal membrane oxygenation procedure based on its mode of cannulation and medical indication is expected to fuel the market growth of the extracorporeal membrane oxygenation market
• Leading players of the market such as Getinge group recently launched its Cardiohelp System and Cardiosave
• Market players are focused in developing the advanced technologies in extracorporeal membrane oxygenation. For instance, MC3 Cardiopulmonary received US FDA approval for its Crescent jugular dual lumen catheter in the US for extracorporeal membrane oxygenation.
• In 2017, CytoSorbents Corporation launched CytoSorb Therapeutic ECMO kit in Austria. The kit combines CytoSorb blood purification cartridge with innovative tubing connector set that provide easy integration in most of the commercial ECMO systems.
• During 2020-2028, extracorporeal membrane oxygenation market is expected to register a CAGR of 4.8% in Asia Pacific; followed by North America and Europe, with 4.6% and 4.1% CAGR, respectively. High prevalence of severe cardiogenic shock and related diseases across the globe is the major factor driving the market during the forecast period across all regions.
• The venoarterial device type of extracorporeal membrane oxygenation segment dominates the field with highest market share in the year 2020. It is estimated to grow at a CAGR of 4.4% during the forecast period to reach USD 156.61 million by 2028
• Based on end use segment, pediatric is expected to account for the CAGR 3.6% of the global extracorporeal membrane oxygenation market, as growing incidences of birth defect and premature birth across the world and raising public awareness about the technologically advanced respiratory support
• Asia Pacific is expected to grow at the highest rate. Developing nations such China, and India are likely to witness high growth due to high prevalence of cardiac and pulmonary diseases, increased healthcare expenditure and growing R&D investment
• High cost of the the procedure and lack of skilled personnel are the key factors likely to hamper growth of the extracorporeal membrane oxygenation market

The ongoing pandemic is significantly changing the dynamics of the pharma and healthcare sector. Various countries are facing challenges such as shortage of medicines, vaccines, healthcare devices in hospitals. This is expected to open lucrative growth opportunities for market players in the coming years.

For Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2465

Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.

Top Companies Profiled in the Report:

Getinge Group (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), XENIOS AG (Germany), Terumo Corporation (Japan), MicroPort Scientific Corporation (China), NIPRO Corporation (Japan), OriGen Biomedical, Inc. (U.S.), ALung Technologies, Inc. (Germany), and EUROSETS S.r.l. (Italy).

Browse Full Report Description with Research Methodology, Table of Content and Infographics @ https://www.reportsanddata.com/report-detail/extracorporeal-membrane-oxygenation-ecmo-market

Extracorporeal Membrane Oxygenation Market Segmentation:

Type Outlook (Revenue, USD Million; 2020-2028)

• Venovenous ECMO
• Venoarterial ECMO
• Arteriovenous ECMO

Component Outlook (Revenue, USD Million; 2020-2028)

• Pumps
• Cannula
• Oxygenators
• Gas Blender
• Heat Exchanger
• Pressure Monitor
• Bladder Reservoir
• Controller
• Gas Cylinder
• Others

Application Outlook (Revenue, USD Million; 2020-2028)

• Congenital Diaphragmatic Hernia (CDH)
• Birth Defects of the Heart
• Meconium Aspiration Syndrome (MAS)
• Severe Pneumonia
• Severe Air Leak Problems
• Severe High Blood Pressure in the Arteries of the Lungs (PPHN)
• Others

Regional Outlook:

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
• Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
• Latin America (Brazil, Rest of LATAM)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/2465

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Explore More Industry Research by Reports and Data:

Point of Care Molecular Diagnostics Market Analysis, By Product And Services (Assay Kits, Software, And Services), By Technology (PCR, IN-Situ Hybridization), By Application (Oncology), By End Use (Decentralized Labs, Hospitals), And Forecasts To 2028 - Download PDF Brochure

Palliative Care Market By Care Type (Hospital Inpatient Care, Private Resident Care, Hospice Resident Care, Nursery and Residential Facility Care, Others), By Application (Cancer, Chronic obstructive pulmonary disease (COPD), Cardiac diseases, Alzheimer’s, Parkinson’s, Kidney failure, Amyotrophic Lateral Sclerosis (ALS), Others), By End-Use (Hospital, Palliative Care centers, Home Care Settings, Long-term Care Centers and Rehabilitation Centers) And By Region, Forecast To 2028 - Download PDF Brochure

Pelvic Organ Prolapse Repair Market Size, Share And Industry Analysis By Treatment Type (Surgical, Non-surgical), By Application (Cystocele, Uterine Prolapse, Rectocele, Enterocele, Others), By End-user (Hospital, Ambulatory Surgical Centers, Clinic, Other) And Region, Segment Forecasts To 2028 - Download PDF Brochure

Peripheral Intravenous Catheters Market By Type (Short Peripheral IV Catheter and Integrated/Closed Peripheral IV Catheter), By Technology, By Application (Renal Disease, Oncology, Pediatric Disease, Gastroenterology, Infectious Disease), And By End Users, Forecast To 2020-2028 - Download PDF Brochure 

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Read the innovative blog at https://www.reportsanddata.com/blogs

Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/videos